Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Hematologic Tests × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 14 Lung Neoplasms 10 Breast Neoplasms 9 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Stomach Neoplasms 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic cancer, adult 2 Ovarian Neoplasms 2 Neoplastic Cells, Circulating 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1

Interventions

Cyclophosphamide 23 blinatumomab 18 Cytarabine 16 fludarabine 13 Azacitidine 12 venetoclax 10 fludarabine phosphate 10 Rituximab 8 Blood Specimen Collection 8 Methotrexate 7 Lenalidomide 7 Dexamethasone 7 Daunorubicin 7 Mercaptopurine 6 Vincristine 5 daratumumab 4 Whole-Body Irradiation 4 Melphalan 4 Idarubicin 4 Etoposide 4 Drug Therapy 4 Busulfan 4 pembrolizumab 3 obinutuzumab 3 Radiotherapy 3 Liquid Biopsy 3 Immunotherapy, Adoptive 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07514715 2026-04-13

RT4

The Lymphoma Academic Research Organisation

Not yet recruiting

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡